Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Oct 12;404(10461):1376-1378.
doi: 10.1016/S0140-6736(24)01823-3.

Progress in breast cancer management

Paolo Tarantino  1 , Sara M Tolaney  2
Affiliations
Editorial

Progress in breast cancer management

Paolo Tarantino et al. Lancet. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

PT reports research funding from AstraZeneca, consulting or advisory roles for AstraZeneca, Daiichi Sankyo, Gilead, Eli Lilly, Genentech, Menarini/Stemline, and Novartis, and honoraria from Roche. SMT reports consulting or advisory roles for Novartis, Pfizer (SeaGen), Merck, Eli Lilly, AstraZeneca, Genentech/Roche, Eisai, Sanofi, Bristol Myers Squibb, CytomX Therapeutics, Daiichi Sankyo, Gilead, Zymeworks, Zentalis, Blueprint Medicines, Reveal Genomics, Sumitovant Biopharma, Umoja Biopharma, Artios Pharma, Menarini/Stemline, Aadi Bio, Bayer, Incyte Corp, Jazz Pharmaceuticals, Natera, Tango Therapeutics, Systimmune, eFFECTOR, Hengrui USA, Cullinan Oncology, Circle Pharma, Arvinas, BioNTech, Johnson & Johnson/Ambrx, Launch Therapeutics, Zuellig Pharma, and Bicycle Therapeutics; research funding from Genentech/Roche, Merck, Exelixis, Pfizer, Lilly, Novartis, Bristol Myers Squibb, Eisai, AstraZeneca, Gilead, NanoString Technologies, Seattle Genetics, OncoPep, Daiichi-Sankyo, and Menarini/Stemline; and travel support from Eli Lilly, Sanofi, Gilead, Jazz Pharmaceuticals, Pfizer, and Arvinas.

Comment on

References

LinkOut - more resources